Long-Term Results of 2-Dimensional Radiation Therapy in Patients with Nasopharyngeal Cancer.
10.3857/jkstro.2010.28.4.193
- Author:
Nam Kwon LEE
1
;
Young Je PARK
;
Dae Sik YANG
;
Won Sup YOON
;
Suk LEE
;
Chul Yong KIM
Author Information
1. Department of Radiation Oncology, Korea University College of Medicine, Seoul, Korea. kcyro@korea.ac.kr
- Publication Type:Original Article
- Keywords:
Nasopharyngeal carcinoma;
Radiation therapy;
Concurrent chemoradiation therapy;
Complications
- MeSH:
Disease-Free Survival;
Female;
Follow-Up Studies;
Hearing Loss;
Humans;
Mucositis;
Multivariate Analysis;
Nasopharyngeal Neoplasms;
Recurrence;
Retrospective Studies;
Trismus
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2010;28(4):193-204
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To analyze the treatment outcomes, complications, prognostic factors after a long-term follow-up of patients with nasopharyngeal carcinoma treated with radiation therapy (RT) alone or concurrent chemoradiation therapy (CCRT). MATERIALS AND METHODS: Between December 1981 and December 2006, 190 eligible patients with non-metastatic nasopharyngeal carcinoma were treated at our department with a curative intent. Of these patients, 103 were treated with RT alone and 87 patients received CCRT. The median age was 49 years (range, 8~78 years). The distributions of clinical stage according to the AJCC 6th edition included I: 7 (3.6%), IIA: 8 (4.2%), IIB: 33 (17.4%), III: 82 (43.2%), IVA: 31 (16.3%), IVB: 29 (15.3%). The accumulated radiation doses to the primary tumor ranged from 66.6~87.0 Gy (median, 72 Gy). Treatment outcomes and prognostic factors were retrospectively analyzed. Acute and late toxicities were assessed using the RTOG criteria. RESULTS: A total of 96.8% (184/190) of patients completed the planned treatment. With a mean follow-up of 73 months (range, 2~278 months; median, 52 months), 93 (48.9%) patients had relapses that were local 44 (23.2%), nodal 13 (6.8%), or distant 49 (25.8%). The 5- and 10-year overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) rates were 55.6% and 44.5%, 54.8% and 51.3%, in addition to 65.3% and 57.4%, respectively. Multivariate analyses revealed that CCRT, age, gender, and stage were significant prognostic factors for OS. The CCRT and gender were independent prognostic factors for both DFS and DSS. There was no grade 4 or 5 acute toxicity, but grade 3 mucositis and hematologic toxicity were present in 42 patients (22.1%) and 18 patients (9.5%), respectively. During follow-up, grade 3 hearing loss in 9 patients and trismus in 6 patients were reported. CONCLUSION: The results of our study were in accordance with findings of previous studies and we confirmed that CCRT, low stage, female gender, and young age were related to improvement in OS. However, there are limitations in the locoregional control that can be achieved by CCRT with 2D conventional radiation therapy. This observation has led to further studies on clarifying the efficacy of concurrent chemotherapy by intensity modulated radiation therapy.
